Servier Announces Positive Topline Data from the Global Phase 3 Study of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia

TIBSOVO is the first targeted therapy to show improved event-free survival and overall survival in combination with azacitidine compared to azacitidine monotherapy. Safety profile consistent with previously published data in patients with IDH1-mutated acute myeloid leukemia. The study recently halted further enrollment due to compelling efficacy data for TIBSOVO. Servier, a global pharmaceutical company, today […]

thaipr.net

2 ส.ค. 64
1 … 3,079 3,080 3,081 3,082 3,083 … 3,536